Loading...
Back to narrative

EXPI: Future Share Buybacks Will Support Upside Repricing

Update shared on 23 Nov 2025

Fair value Increased 8.33%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-16.2%
7D
11.5%

Analysts have raised their price target for eXp World Holdings from $12.00 to $13.00 per share. They cite stronger projected revenue growth and improved profit margins as key factors in the upward revision.

What's in the News

  • eXp World Holdings completed a significant share buyback, repurchasing 1,589,685 shares for $15.94 million between July and October 2025 (Key Developments)
  • This latest tranche brings the total repurchased shares to 47,957,832, or about 31.97% of outstanding shares. The cumulative cost reached $777.35 million (Key Developments)
  • The current buyback program was originally announced in December 2018 (Key Developments)

Valuation Changes

  • Fair Value: Increased from $12.00 to $13.00 per share
  • Discount Rate: Rose slightly from 8.27% to 8.59%
  • Revenue Growth: Grew from 3.6% to 6.01%
  • Net Profit Margin: Improved significantly from 20.3% to 64.8%
  • Future P/E: Dropped notably from 246.6x to 79.8x

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.